Comprehensive Analysis of the Anaphylaxis Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the anaphylaxis market grown over the years?
In recent times, the anaphylaxis market has experienced robust growth. The market is projected to expand from $3.24 billion in 2024 to $3.51 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. Factors contributing to the growth during the historic period include the escalating rate of food allergies, elevated awareness of anaphylaxis, improvement in healthcare infrastructure, enhanced diagnosis and management strategies, and the rising availability of epinephrine auto-injectors.
What Is the forecasted market size and growth rate for the anaphylaxis market?
Anticipated robust growth in the anaphylaxis market could increase its size to $4.81 billion by 2029, with a compound annual growth rate (CAGR) of 8.2%. This potential growth throughout the predicted period is due to several factors: the burgeoning urbanization and shifting lifestyles, a rise in anaphylaxis cases, higher disposable earnings in budding markets, governmental contributions for allergy-based research, and breakthroughs in delivery systems designed for emergency interventions. The forecast also identifies key trends, which include increased demand for auto-injector injections, incorporation of digital health strategies for managing anaphylaxis, greater emphasis on product cost-effectiveness, escalation in preemptive treatments and vaccines, and expanded application of biological products in allergy treatments.
Get your anaphylaxis market report here!
https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report
What are the major factors driving growth in the anaphylaxis market?
The increasing incidence of food allergies is projected to fuel the expansion of the anaphylaxis market. Food allergies, which are responses of the immune system triggered by specific foods causing symptoms ranging from mild to severe, including potential deadly anaphylaxis, are on the rise. This increased frequency is attributed to factors like altered dietary patterns, environmental impacts, and better recognition and diagnosis. Anaphylaxis treatment offers vital intervention for patients with food allergies by quickly reversing severe allergic reactions, alleviating symptoms like swelling, respiratory struggle, and a decrease in blood pressure. This ensures immediate stabilization and prevention of potentially lethal outcomes while equipping patients to manage future allergic episodes promptly. For example, the World Health Organization (WHO), a UN organization based in Switzerland, noted in September 2024 that around 220 million people worldwide have food allergies. A single food item can contain many allergens, and a person may be allergic to more than one food type. Moreover, in May 2024, the Patterns and Prevalence of Adult Food Allergy (PAFA) report published by the Food Standards Agency (FSA), a non-ministerial department in the UK, stated that over 30% of adults had adverse reactions to food, and medical evaluations confirmed food allergies in about 6% of UK adults, or approximately 2.4 million people. Hence, the increasing frequency of food allergies is contributing to the enlargement of the anaphylaxis market.
What key areas define the segmentation of the global anaphylaxis Market?
The anaphylaxis market covered in this report is segmented –
1) By Drug Class: Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class
2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration
3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications
Subsegments:
1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials
2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids
3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists
4) By Beta-antagonists: Selective Beta-blockers, Non-selective Beta-blockers
5) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp
What are the top market players propelling the growth of the anaphylaxis industry?
Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics
What are the key trends shaping the future of the anaphylaxis market?
Significant players in the anaphylaxis market are emphasizing the development of sophisticated epinephrine nasal sprays for quicker and more effective drug delivery in emergency situations. An epinephrine nasal spray is a medical instrument that administers epinephrine (also known as adrenaline) via the nasal cavity to treat severe allergic reactions such as anaphylaxis. For example, in August 2024, US biotech firm ARS Pharmaceuticals declared that its product, Neffy (an epinephrine nasal spray), had been approved by the US government agency, the Food and Drug Administration. This marked it the first and exclusive needle-free therapy for type I allergic reactions, including anaphylaxis. This novel nasal spray provides a non-invasive alternative to conventional epinephrine autoinjectors and potentially offers a more easily available option for emergency treatment. Neffy is designed to enhance patient adherence by removing the need for needles, while delivering fast, life-saving epinephrine during intense allergic reactions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21096
What regions are dominating the anaphylaxis market growth?
North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Vaccine Adjuvants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report
Enzyme Inhibitor Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/enzyme-inhibitor-global-market-report
Focal Segmental Glomerulosclerosis Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
